Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events effect consort pro extension pro reporting standards
… Webinar: Characteristics of Recent PRO Labeling by the FDA and EMA for Oncology Drugs Share on: … for cancer treatment found that the agencies use different standards to evaluate evidence from patient-reported outcomes … (PROs) in clinical trials. Study sponsors pursuing PRO drug labeling who understand these differences can use …
… PRO Analysis Portfolio Across Multiple Cancers OPPORTUNITY … Additionally, we needed to account for differences in reporting requirements across the trials for both clinical … the result. Analyses included: Descriptive analyses of PRO questionnaire completion rates and score changes over …
… RTI-HS Webinar - Lessons Learned From a Review of FDA PRO Labeling Share on: December 12, 2016 Image Click to view this webinar - Lessons Learned from a Review of FDA PRO Labeling The last decade has seen an increased focus on … Product labeling based on patient-reported outcomes (PRO) endpoints are therefore of special interest to drug …
… outcome such as a health state event or treatment side-effect. Utility scores are used in health economic models … Develop a health preference index from a disease-specific PRO instrument - Conduct health preference assessments using … and standard gamble - Capture utility data real-time, as events occur, via mobile technology solutions (e.g., …
… and Projected Value Assessments: Clinical, economic, PRO /QoL value A Roadmap: Tactical project and study …
… and evaluated the psychometric properties of hundreds of PRO instruments and other types of COAs to assess health …
… differences so that you can determine the average effect of your medicine in any particular controlled group. … genetics, age, gender, physiology, geography, standards of care, or even expectations and preferences—for … claims - Inform safety studies and reduce risks of adverse events Abandoned Drugs - Rescue, repurpose, or resurrect …
… discussion of the steps needed to successfully implement PRO measurement within the drug development program to … value messages. Formulation of a successful PRO strategy requires an understanding of PRO instrument selection, psychometric evaluation, data …
… assessments (COAs), including patient-reported outcome (PRO), observer-reported outcome (ObsRO), clinician-reported …
… acceptable to the FDA following the release of the FDA’s PRO Guidance. To support these efforts, we have developed … as well as guiding industry clients through the EMA’s PRO Scientific Advice and Biomarker qualification processes. …